nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—ADRB2—polycystic ovary syndrome	0.886	1	CbGaD
Terbutaline—ADRB2—Adrenoceptors—ADRA1D—polycystic ovary syndrome	0.0065	0.0654	CbGpPWpGaD
Terbutaline—ADRB2—Adrenoceptors—ADRA1B—polycystic ovary syndrome	0.00633	0.0636	CbGpPWpGaD
Terbutaline—ADRB2—Adrenoceptors—ADRA1A—polycystic ovary syndrome	0.00479	0.0482	CbGpPWpGaD
Terbutaline—ADRB2—Adrenoceptors—ADRB3—polycystic ovary syndrome	0.00461	0.0464	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 trafficking events—MAPK8IP3—polycystic ovary syndrome	0.00321	0.0323	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—LHCGR—polycystic ovary syndrome	0.00242	0.0243	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0023	0.0231	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.00224	0.0225	CbGpPWpGaD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—polycystic ovary syndrome	0.00197	0.0198	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00194	0.0195	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.00193	0.0194	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.00188	0.0189	CbGpPWpGaD
Terbutaline—BCHE—Glycerophospholipid biosynthesis—LPCAT2—polycystic ovary syndrome	0.00173	0.0173	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.0017	0.017	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.00163	0.0164	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00147	0.0148	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.00143	0.0143	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.00137	0.0138	CbGpPWpGaD
Terbutaline—Fenoterol—ADRB3—polycystic ovary syndrome	0.0012	0.0858	CrCbGaD
Terbutaline—BCHE—Phospholipid metabolism—LPCAT2—polycystic ovary syndrome	0.0012	0.0121	CbGpPWpGaD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—polycystic ovary syndrome	0.00119	0.0119	CbGpPWpGaD
Terbutaline—Phenylephrine—ADRA1D—polycystic ovary syndrome	0.00118	0.0844	CrCbGaD
Terbutaline—Clenbuterol—ADRB3—polycystic ovary syndrome	0.00118	0.0838	CrCbGaD
Terbutaline—Bupranolol—ADRB3—polycystic ovary syndrome	0.00116	0.0829	CrCbGaD
Terbutaline—BCHE—Glycerophospholipid biosynthesis—PNPLA2—polycystic ovary syndrome	0.00114	0.0115	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00111	0.0112	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.00102	0.0103	CbGpPWpGaD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—polycystic ovary syndrome	0.00101	0.0102	CbGpPWpGaD
Terbutaline—Phenylephrine—ADRA1B—polycystic ovary syndrome	0.00101	0.072	CrCbGaD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—polycystic ovary syndrome	0.00098	0.00985	CbGpPWpGaD
Terbutaline—Bambuterol—ADRB2—polycystic ovary syndrome	0.000905	0.0646	CrCbGaD
Terbutaline—ADRB2—G alpha (s) signalling events—LHCGR—polycystic ovary syndrome	0.000878	0.00883	CbGpPWpGaD
Terbutaline—Orciprenaline—ADRB2—polycystic ovary syndrome	0.000851	0.0607	CrCbGaD
Terbutaline—BCHE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000824	0.00828	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—FSHR—polycystic ovary syndrome	0.000823	0.00828	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PNPLA2—polycystic ovary syndrome	0.000797	0.00801	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 trafficking events—SLC2A4—polycystic ovary syndrome	0.000734	0.00738	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—PDE3B—polycystic ovary syndrome	0.000706	0.00709	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.000689	0.00692	CbGpPWpGaD
Terbutaline—Pirbuterol—ADRB2—polycystic ovary syndrome	0.000686	0.0489	CrCbGaD
Terbutaline—Phenylephrine—ADRA1A—polycystic ovary syndrome	0.00068	0.0485	CrCbGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.00067	0.00673	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—FSHR—polycystic ovary syndrome	0.000643	0.00646	CbGpPWpGaD
Terbutaline—Isoprenaline—ADRB3—polycystic ovary syndrome	0.000588	0.0419	CrCbGaD
Terbutaline—ADRB2—G alpha (s) signalling events—ADRB3—polycystic ovary syndrome	0.000566	0.00569	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—LHB—polycystic ovary syndrome	0.000559	0.00562	CbGpPWpGaD
Terbutaline—Epinephrine—ADRA1D—polycystic ovary syndrome	0.00055	0.0392	CrCbGaD
Terbutaline—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000544	0.00547	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.000527	0.0053	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—SCT—polycystic ovary syndrome	0.000524	0.00527	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.000508	0.0051	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000506	0.00509	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.000502	0.00504	CbGpPWpGaD
Terbutaline—Epinephrine—ADRB3—polycystic ovary syndrome	0.000494	0.0352	CrCbGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.000489	0.00491	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.000489	0.00491	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.000489	0.00491	CbGpPWpGaD
Terbutaline—Epinephrine—ADRA1B—polycystic ovary syndrome	0.000469	0.0335	CrCbGaD
Terbutaline—Fenoterol—ADRB2—polycystic ovary syndrome	0.000458	0.0326	CrCbGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.000457	0.00459	CbGpPWpGaD
Terbutaline—Clenbuterol—ADRB2—polycystic ovary syndrome	0.000447	0.0319	CrCbGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.000444	0.00446	CbGpPWpGaD
Terbutaline—Bupranolol—ADRB2—polycystic ovary syndrome	0.000442	0.0315	CrCbGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000432	0.00434	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000419	0.00421	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000419	0.00421	CbGpPWpGaD
Terbutaline—Salbutamol—ADRB2—polycystic ovary syndrome	0.000416	0.0296	CrCbGaD
Terbutaline—ADRB2—Arf6 trafficking events—INS—polycystic ovary syndrome	0.000412	0.00414	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000392	0.00394	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000388	0.0039	CbGpPWpGaD
Terbutaline—Clenbuterol—CYP1A1—polycystic ovary syndrome	0.000383	0.0273	CrCbGaD
Terbutaline—ADRB2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000382	0.00384	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00038	0.00382	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00037	0.00372	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000366	0.00368	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000358	0.0036	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000352	0.00354	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000335	0.00337	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000327	0.00329	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000327	0.00329	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000319	0.0032	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000319	0.0032	CbGpPWpGaD
Terbutaline—Epinephrine—ADRA1A—polycystic ovary syndrome	0.000316	0.0225	CrCbGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000315	0.00317	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000306	0.00308	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000306	0.00308	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000306	0.00308	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000303	0.00304	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000298	0.003	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00029	0.00291	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000283	0.00285	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000282	0.00283	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000281	0.00283	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00028	0.00282	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00028	0.00281	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000278	0.0028	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000277	0.00279	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000277	0.00279	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00027	0.00272	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00027	0.00271	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000268	0.00269	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000267	0.00268	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000261	0.00262	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000257	0.00258	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000245	0.00246	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000243	0.00245	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000238	0.0024	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000233	0.00235	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000232	0.00233	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000232	0.00233	CbGpPWpGaD
Terbutaline—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000224	0.0159	CrCbGaD
Terbutaline—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000216	0.00217	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000213	0.00215	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00021	0.00211	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000205	0.00207	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.000205	0.00206	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000203	0.00204	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000198	0.00199	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000197	0.00198	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000196	0.00197	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000195	0.00196	CbGpPWpGaD
Terbutaline—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000192	0.0137	CrCbGaD
Terbutaline—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000191	0.00192	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000191	0.00192	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000191	0.00192	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00019	0.00191	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000189	0.0019	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000189	0.0019	CbGpPWpGaD
Terbutaline—Epinephrine—ADRB2—polycystic ovary syndrome	0.000188	0.0134	CrCbGaD
Terbutaline—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000181	0.00182	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00018	0.00181	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00018	0.00181	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00018	0.00181	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000177	0.00178	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000176	0.00177	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000176	0.00177	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000173	0.00173	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.000173	0.00173	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00017	0.00171	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000169	0.00169	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000164	0.00164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000164	0.00164	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000164	0.00164	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.00016	0.00161	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000159	0.0016	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000157	0.00158	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000156	0.00156	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000153	0.00154	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000149	0.00149	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000146	0.00147	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000145	0.00146	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000145	0.00145	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000139	0.0014	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000139	0.0014	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000136	0.00137	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000136	0.00137	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000134	0.00135	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000133	0.00133	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000132	0.00133	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000131	0.00132	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000131	0.00132	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000129	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000121	0.00121	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00012	0.0012	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000116	0.00117	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000116	0.00116	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000115	0.00116	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000115	0.00115	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000114	0.00115	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000112	0.00113	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00011	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000108	0.00109	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000108	0.00108	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000105	0.00106	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000105	0.00105	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000104	0.00105	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.000103	0.00104	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000103	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000103	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000103	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000102	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000102	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	9.95e-05	0.001	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	9.76e-05	0.000981	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	9.67e-05	0.000972	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	9.67e-05	0.000972	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	9.55e-05	0.00096	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	9.31e-05	0.000936	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMMR—polycystic ovary syndrome	9.22e-05	0.000926	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	9.1e-05	0.000914	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	9.04e-05	0.000909	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	8.79e-05	0.000884	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.78e-05	0.000882	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.69e-05	0.000873	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	8.54e-05	0.000858	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	8.32e-05	0.000836	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.24e-05	0.000828	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LHB—polycystic ovary syndrome	8.02e-05	0.000806	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	7.84e-05	0.000788	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.77e-05	0.000781	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	7.59e-05	0.000763	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.57e-05	0.000761	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	7.08e-05	0.000711	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	6.98e-05	0.000702	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.93e-05	0.000696	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.88e-05	0.000691	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—RRM2—polycystic ovary syndrome	6.76e-05	0.00068	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.65e-05	0.000669	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—YAP1—polycystic ovary syndrome	6.52e-05	0.000655	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.47e-05	0.00065	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	6.31e-05	0.000634	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	6.26e-05	0.00063	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	6.23e-05	0.000626	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.23e-05	0.000626	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	6.19e-05	0.000622	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	6.18e-05	0.000621	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	6.15e-05	0.000619	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.14e-05	0.000617	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.02e-05	0.000605	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	5.84e-05	0.000587	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.83e-05	0.000586	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.81e-05	0.000584	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	5.77e-05	0.00058	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	5.75e-05	0.000578	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.5e-05	0.000553	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	5.41e-05	0.000543	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	5.36e-05	0.000539	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	5.31e-05	0.000533	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.28e-05	0.000531	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	5.28e-05	0.00053	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	5.11e-05	0.000513	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	5.01e-05	0.000503	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TH—polycystic ovary syndrome	4.98e-05	0.0005	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.94e-05	0.000496	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	4.84e-05	0.000487	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.72e-05	0.000474	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	4.55e-05	0.000457	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.49e-05	0.000451	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.42e-05	0.000444	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	4.37e-05	0.000439	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	4.06e-05	0.000408	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	4.06e-05	0.000408	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GNAS—polycystic ovary syndrome	4.06e-05	0.000408	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.91e-05	0.000393	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.88e-05	0.00039	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	3.87e-05	0.000389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.78e-05	0.00038	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.76e-05	0.000378	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	3.67e-05	0.000369	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.58e-05	0.00036	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.55e-05	0.000357	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.55e-05	0.000356	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	3.42e-05	0.000344	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.42e-05	0.000343	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	3.12e-05	0.000313	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.97e-05	0.000299	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.92e-05	0.000293	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARG—polycystic ovary syndrome	2.77e-05	0.000279	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—POMC—polycystic ovary syndrome	2.74e-05	0.000275	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—INS—polycystic ovary syndrome	2.72e-05	0.000273	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.5e-05	0.000251	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.44e-05	0.000246	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.18e-05	0.000219	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	2.1e-05	0.000211	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	2.09e-05	0.00021	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.02e-05	0.000203	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.02e-05	0.000203	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.92e-05	0.000193	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.54e-05	0.000155	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.32e-05	0.000133	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	9.13e-06	9.17e-05	CbGpPWpGaD
